Search

everythinglearnresearchcommunity

for

Search:↓

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

PCOS has three subtypes, with 11-oxygenated androgens increasing metabolic risk.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

A rare tumor caused unusual hormone production leading to Cushing syndrome.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Hair loss in postmenopausal woman caused by ovarian issue.

PCOS is a common inherited condition causing cysts, irregular periods, and increased diabetes risk in women.

Early hormones shape sex-specific differences in rat glands.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

The book explains how excess male hormones can affect various conditions like Polycystic Ovary Syndrome and Cushing's disease.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

PCOS patients have higher LDH and lower cortisol, dopamine, zinc, and vitamin D3, which may contribute to their symptoms and obesity.

Hirsutism in women is mostly due to PCOS and can be managed with oral contraceptives and hair removal methods.

Rodent models of PCOS show some similar and some different lipid changes compared to humans.

Latanoprost eye drops caused excessive hair growth and eyelash whitening in a woman.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Polymenorrhoea should be included in PCOS diagnostic criteria due to similar metabolic issues.